Alliance Pharma Plc (APH):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Alliance Pharma Plc (APH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9767
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alliance Pharma Plc (Alliance) is a specialty pharmaceutical company. It focuses on acquisition, licensing, registration and marketing of pharmaceutical products. It promotes acquired and licensed prescription products across various therapeutic categories such as dermatology, central nervous system, women’s health, infectious disease, cardiovascular, respiratory, immunology, gastrointestinal, oncology, nutrition, toxicology and mouth and dental disorders. The company distributes its products through wholesalers, retail pharmacies, hospitals and international network of distributors. It operates in the UK, Ireland, British Virgin Islands, France and Germany. Alliance is headquartered in Chippenham, Wiltshire, the UK.

Alliance Pharma Plc (APH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Alliance Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Alliance Pharma Acquires Nizoral from Janssen Pharma for USD79.5 Million 11
Alliance Pharma Acquires Rights of Vamousse from TyraTech 12
Alliance Pharma Acquires Healthcare Products Business from Sinclair IS Pharma for USD198.4 Million 13
Alliance Pharma Acquires Rights of Nutraceutical Brands from Sinopharm Nutraceuticals for USD2.1 Million 14
Alliance Pharma Acquires Rights To Irenat From Bayer 15
Alliance Pharma Acquires Rights To Lypsyl From Novartis For US$3 Million 16
Alliance Pharma Acquires Overseas Rights To Syntometrine From Novartis For US$11.5 Million 17
Alliance Pharma Acquires Antimalarial Drug Brands From AstraZeneca UK For US$8 Million 18
Alliance Pharma Completes Acquisition Of UK And Irish Rights To Anbesol And Ashton & Parsons From Reckitt Benckiser For US$4 Million 19
Licensing Agreements 20
Alliance Pharma Enters into Licensing Agreement with Duchesnay for Diclectin 20
Equity Offering 21
Alliance Pharma Raises USD45 Million in Private Placement of Shares 21
Alliance Pharma Raises USD7.6 Million in Private Placement of Shares 22
Acquisition 23
Pacific Glory Development to Acquire 60% Stake in Unigreg for USD4 Million 23
Alliance Pharma Acquires MacuVision 24
Alliance Pharma Acquires Opus, Healthcare Products Distributor, For US$15.3 Million 25
Alliance Pharma Plc – Key Competitors 26
Alliance Pharma Plc – Key Employees 27
Alliance Pharma Plc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 30
Financial Announcements 30
Sep 19, 2018: Alliance Pharma announces interim results for the six months ended 30 June 2018 30
Jul 25, 2018: Alliance Pharma: half year trading update 37
Mar 27, 2018: APH Full Year Results 38
Mar 27, 2018: Alliance Pharma: Results for the year ended 31 December 2017 39
Sep 13, 2017: Alliance Pharma: Interim Results for the six months ended 30 June 2017 44
Jul 18, 2017: Alliance Pharma: Half Year Trading Update 45
Mar 29, 2017: Alliance Pharma: Results for the year ended 31 December 2016 46
Jan 23, 2017: Alliance Pharma Announces Pre-Close Trading Update 47
Corporate Communications 48
May 30, 2018: Alliance Pharma: Directorate Change 48
Mar 01, 2018: Alliance Pharma: Directorate Changes 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Alliance Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Alliance Pharma Plc, Deals By Therapy Area, 2012 to YTD 2018 9
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alliance Pharma Acquires Nizoral from Janssen Pharma for USD79.5 Million 11
Alliance Pharma Acquires Rights of Vamousse from TyraTech 12
Alliance Pharma Acquires Healthcare Products Business from Sinclair IS Pharma for USD198.4 Million 13
Alliance Pharma Acquires Rights of Nutraceutical Brands from Sinopharm Nutraceuticals for USD2.1 Million 14
Alliance Pharma Acquires Rights To Irenat From Bayer 15
Alliance Pharma Acquires Rights To Lypsyl From Novartis For US$3 Million 16
Alliance Pharma Acquires Overseas Rights To Syntometrine From Novartis For US$11.5 Million 17
Alliance Pharma Acquires Antimalarial Drug Brands From AstraZeneca UK For US$8 Million 18
Alliance Pharma Completes Acquisition Of UK And Irish Rights To Anbesol And Ashton & Parsons From Reckitt Benckiser For US$4 Million 19
Alliance Pharma Enters into Licensing Agreement with Duchesnay for Diclectin 20
Alliance Pharma Raises USD45 Million in Private Placement of Shares 21
Alliance Pharma Raises USD7.6 Million in Private Placement of Shares 22
Pacific Glory Development to Acquire 60% Stake in Unigreg for USD4 Million 23
Alliance Pharma Acquires MacuVision 24
Alliance Pharma Acquires Opus, Healthcare Products Distributor, For US$15.3 Million 25
Alliance Pharma Plc, Key Competitors 26
Alliance Pharma Plc, Key Employees 27
Alliance Pharma Plc, Subsidiaries 28

List of Figures
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Alliance Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

★海外企業調査レポート[Alliance Pharma Plc (APH):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NIIT Ltd (NIITLTD):企業の財務・戦略的SWOT分析
    NIIT Ltd (NIITLTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Beach Energy Limited:企業の戦略・SWOT・財務情報
    Beach Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Beach Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Musgrave Group Plc:企業の戦略・SWOT・財務情報
    Musgrave Group Plc - Strategy, SWOT and Corporate Finance Report Summary Musgrave Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Astrotech Corporation
    Astrotech Corporation - Strategy, SWOT and Corporate Finance Report Summary Astrotech Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Berkley Renewables Inc (BKS):企業の財務・戦略的SWOT分析
    Berkley Renewables Inc (BKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • National Health Insurance Company – Daman PJSC:企業の戦略・SWOT・財務情報
    National Health Insurance Company - Daman PJSC - Strategy, SWOT and Corporate Finance Report Summary National Health Insurance Company - Daman PJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Allianz Global Corporate & Specialty Singapore:企業の戦略・SWOT・財務分析
    Allianz Global Corporate & Specialty Singapore - Strategy, SWOT and Corporate Finance Report Summary Allianz Global Corporate & Specialty Singapore - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Scientex Bhd (SCIENTX):企業の財務・戦略的SWOT分析
    Summary Scientex Bhd (Scientex) is a manufacturer and supplier of packaging products and component parts for automotive interior. The company operates through stretch and custom film, converting, specialty products and property development divisions. It offers lamination base, general, barrier and a …
  • Centre for Commercialization of Regenerative Medicine:製薬・医療:M&Aディール及び事業提携情報
    Summary Centre for Commercialization of Regenerative Medicine (CCRM) is a healthcare service provider that offers cell reprogramming and engineering, cell manufacturing, biomaterials and devices manufacturing, and protocol development services. The center harnesses the power of stem cells, biomateri …
  • JCR Pharmaceuticals Co Ltd (4552):企業の財務・戦略的SWOT分析
    JCR Pharmaceuticals Co Ltd (4552) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Dyas BV:石油・ガス:M&Aディール及び事業提携情報
    Summary Dyas BV (Dyas) a subsidiary of SHV Holdings N.V., is an oil and gas company that offers oil exploration and production programs. The company offers products which include crude oil and natural gas. It operates projects which include Buzzard, Broom, Elgin and Franklin; Bergen, Middelie, Zuid …
  • Vivakor Inc (VIVK):石油・ガス:M&Aディール及び事業提携情報
    Summary Vivakor Inc (Vivakor) is a technology and asset acquisition company that creates, acquires and accumulates distinct assets, intellectual properties, and various technologies. The company concentrates on precious metals extraction in the US. It also concentrates on oil extraction from shallow …
  • Honeywell International Inc.:企業の戦略・SWOT・財務情報
    Honeywell International Inc. - Strategy, SWOT and Corporate Finance Report Summary Honeywell International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Entegris Inc (ENTG):企業の財務・戦略的SWOT分析
    Summary Entegris Inc (Entegris) is a manufacturer and supplier of micro contamination control products, specialty chemicals, and advanced materials handling solutions. The company offers products for wafer shipping and processing; gas filtration and purification; mask and reticle handling; hard disk …
  • Leica Microsystems GmbH:企業のM&A・事業提携・投資動向
    Leica Microsystems GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Leica Microsystems GmbH Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Strata-X Energy Ltd (SXE):石油・ガス:M&Aディール及び事業提携情報
    Summary Strata-X Energy Ltd (Strata-X Energy), formerly Strata-X Ltd, is an independent oil and gas exploration company. The company operates in the acquisition, exploration and development of oil and gas properties in the US states of California and Illinois and in the Republic of Botswana. It prov …
  • Sanara MedTech Inc (WNDM):企業の財務・戦略的SWOT分析
    Summary Sanara MedTech Inc (Sanara MedTech), formerly WNDM Medical Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone bleeding. Its pro …
  • Ework Group AB (EWRK):企業の財務・戦略的SWOT分析
    Ework Group AB (EWRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • LPL Financial Holdings Inc (LPLA):企業の財務・戦略的SWOT分析
    LPL Financial Holdings Inc (LPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Telecom Plus plc (TEP):電力:M&Aディール及び事業提携情報
    Summary Telecom Plus plc (Telecom Plus), trading as The Utility Warehouse, is a provider of utility services. It supplies basic utilities such as energy, home phone, broadband and mobile services, and provides the bill of the services in a single monthly statement. Its services include fixed and mob …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆